Tiziana Life Sciences (TLSA) has released an update.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Tiziana Life Sciences Ltd. has announced the voluntary resignation of its Chief Operating Officer and Chief Medical Officer, Matthew W Davis, MD, RPh, effective from August 2, 2024. The departure is due to personal reasons, with no reported disputes concerning company operations, policies, or practices. A search for Dr. Davis’ successor is underway, with further updates to come once a replacement is appointed.
For further insights into TLSA stock, check out TipRanks’ Stock Analysis page.
